The closing price of Geron Corp. (NASDAQ: GERN) was $2.25 for the day, up 7.14% from the previous closing price of $2.10. In other words, the price has increased by $+0.1500 from its previous closing price. On the day, 9003393 shares were traded.
Ratios:
Our analysis of GERN’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 3.16 and its Current Ratio is at 3.16. In the meantime, Its Debt-to-Equity ratio is 0.35 whereas as Long-Term Debt/Eq ratio is at 0.15.
On March 28, 2023, Goldman started tracking the stock assigning a Neutral rating and target price of $3.
On October 28, 2022, Wedbush started tracking the stock assigning a Outperform rating and target price of $5.Wedbush initiated its Outperform rating on October 28, 2022, with a $5 target price.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Aug 24 ’23 when O’Farrell Elizabeth G. bought 6,607 shares for $2.28 per share. The transaction valued at 15,064 led to the insider holds 7,407 shares of the business.
O’Farrell Elizabeth G. bought 6,579 shares of GERN for $15,000 on Aug 24 ’23. The Director now owns 26,220 shares after completing the transaction at $2.28 per share. On May 11 ’23, another insider, LAWLIS V BRYAN, who serves as the Director of the company, sold 35,000 shares for $3.00 each. As a result, the insider received 105,000 and left with 0 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, GERN now has a Market Capitalization of 1.23B and an Enterprise Value of 981.60M. For the stock, the TTM Price-to-Sale (P/S) ratio is 5119.31 while its Price-to-Book (P/B) ratio in mrq is 4.94. Its current Enterprise Value per Revenue stands at 4.14k whereas that against EBITDA is -5.62.
Stock Price History:
Over the past 52 weeks, GERN has reached a high of $3.73, while it has fallen to a 52-week low of $1.68. The 50-Day Moving Average of the stock is 2.0410, while the 200-Day Moving Average is calculated to be 2.3863.
Shares Statistics:
GERN traded an average of 7.10M shares per day over the past three months and 9.88M shares per day over the past ten days. A total of 544.91M shares are outstanding, with a floating share count of 447.58M. Insiders hold about 18.03% of the company’s shares, while institutions hold 55.15% stake in the company. Shares short for GERN as of Feb 15, 2024 were 43.57M with a Short Ratio of 6.14, compared to 39.79M on Jan 12, 2024. Therefore, it implies a Short% of Shares Outstanding of 8.02% and a Short% of Float of 8.06%.
Earnings Estimates
The firm’s stock currently is rated by 6 analysts. On average, analysts expect EPS of -$0.1 for the current quarter, with a high estimate of -$0.09 and a low estimate of -$0.1, while EPS last year was -$0.07. The consensus estimate for the next quarter is -$0.11, with high estimates of -$0.1 and low estimates of -$0.12.
Analysts are recommending an EPS of between -$0.29 and -$0.39 for the fiscal current year, implying an average EPS of -$0.33. EPS for the following year is -$0.17, with 5 analysts recommending between -$0.01 and -$0.37.
Revenue Estimates
A total of 5 analysts have provided revenue estimates for GERN’s current fiscal year. The highest revenue estimate was $99.35M, while the lowest revenue estimate was $8.99M, resulting in an average revenue estimate of $53.07M. In the same quarter a year ago, actual revenue was $237k, up 22,292.40% from the average estimate. Based on 6 analysts’ estimates, the company’s revenue will be $244.44M in the next fiscal year. The high estimate is $378.5M and the low estimate is $39.91M. The average revenue growth estimate for next year is up 360.60% from the average revenue estimate for this year.
